Presenting a sham treatment as personalised increases the placebo effect in a randomised controlled trial.
Dasha A Sandra, Jay A Olson, Ellen J Langer...
https://pubmed.ncbi.nlm.nih.gov/37405829/Actively Recruiting
Led by Trustees of Dartmouth College · Updated on 2026-06-11
196
Participants Needed
1
Research Sites
26 weeks
Total Duration
This research aims to explore whether non-invasive brain stimulation called transcranial temporal interference stimulation tTIS can reduce negative emotions and how expectations from care providers influence these effects. The study focuses on two main questions if active tTIS reduces negative affect more than a sham inactive version, and whether positive treatment expectations improve these effects. The study includes participants acting as patients and doctors to investigate these effects through multiple sessions. Participants take part in two experiments. In Experiment 1, 36 participants complete four sessions combining active or sham tTIS with positive or negative placebo messaging in a crossover design, receiving stimulation for 20 minutes or a brief sham stimulation. In Experiment 2, 160 participants 120 patients and 40 doctors engage in two sessions with sham tTIS only, where doctors deliver placebo interventions and monitor patient responses. Stimulation targets the anteriormid-cingulate cortex using specific frequencies and intensities. During the study, participants complete negative affect tasks before and after each stimulation. Physiological measures like ECG, respiration, skin conductance, and others are recorded. MRI scans and behavioral assessments are also performed. Researchers measure cognitive effort, fear, and pain ratings, along with autonomic responses, to evaluate the effects. Sessions are spaced at least 48 hours apart, and the entire testing occurs within one month.
CONDITIONS
Neural Mechanisms of Interpersonal Expectations on Negative Affect
Z
Zhaoxing Wei, Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Trustees of Dartmouth College
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Active tTIS with positive placebo | Sham tTIS with positive placebo | Active tTIS with negative placebo | Sham tTIS with negative placebo |
|---|---|---|---|---|
| What is it? | Participants receive active non-invasive brain stimulation (tTIS) targeting emotion-relevant brain regions, combined with positive messaging from the provider to enhance expectation of benefit. | Participants receive sham tTIS (device simulates stimulation without real effect), along with positive messaging to enhance expectation of benefit. | Participants receive active tTIS brain stimulation but are given skeptical or neutral messaging prior to the procedure (negative expectancy/placebo). | Participants experience sham tTIS (no true stimulation) combined with skeptical or neutral provider messaging before tasks. |
| Role in the trial | Tests the combined impact of active brain stimulation and a positive expectation on participant emotion and pain response. | Isolates the effect of positive expectancy without actual tTIS stimulation during key tasks. | Examines whether active tTIS alters emotion and pain ratings when expectations are not enhanced. | Acts as a control for both stimulation and expectation, observing effect of negative expectancy alone. |
| Primary use in this study | To examine if pairing positive expectation with active tTIS changes negative emotional response and pain, as measured by task ratings. | To show how positive expectancy without real stimulation affects emotion and pain task ratings. | To determine if active tTIS exerts effects on pain and negative affect when not reinforced by positive expectation. | Serves as a full negative control for expectancy and stimulation, anchoring baseline effects. |
| How is it given? | Active tTIS is delivered non-invasively at 2 mA per channel for 20 minutes targeting the aMCC, paired with provider-delivered positive expectancy messaging. Participants complete negative affect tasks before and after stimulation. | Sham tTIS simulates current for 80 seconds, then stops, while provider gives positive expectancy messaging. Negative affect tasks are completed before and after. | Active tTIS (2 mA per channel, 20 minutes) is delivered with neutral or skeptical expectancy messaging, and pre- and post-task completion. | Sham tTIS mimics stimulation for 80 seconds only, with negative or skeptical messaging from the provider. Participants complete the tasks as in other sessions. |
| What is already known from research? | Non-invasive tTIS can deliver electrical stimulation to deep brain regions and is being studied for effects on emotional processing, but its impact on negative affect in healthy people remains experimentally unproven. | Sham tTIS is designed to mimic the experience of stimulation without actually targeting brain regions, so it should not have a direct physiological impact; however, positive expectancy (placebo effect) can influence perceived outcomes. | Active tTIS may influence task ratings, but if expectations are not enhanced, effects may differ or be reduced; little prior research exists specifically on negative expectancy with tTIS. | Sham tTIS with neutral or negative expectancy is not expected to affect emotion or pain, but research is limited on whether skepticism interacts with placebo response in this context. |
| Important limitations | Findings may not apply to clinical populations or real-world emotional distress. Effects are assessed in healthy volunteers, and both the stimulation protocol and expectancy messaging may not generalize beyond the study setting. | Results may be highly influenced by participant awareness and individual variability in response to expectancy; sham protocols may also not fully mimic all aspects of real stimulation. | The effect of negative expectancy in combination with stimulation is not well established, and outcomes may be shaped by subtle social cues unique to the research environment. | No direct physiological stimulation and negative expectancy together may produce baseline effects only; unclear if findings can predict outcomes in clinical or higher stress settings. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Four sessions over at least 2 weeks
Participants complete four sessions combining active or sham brain stimulation with positive or negative placebo messaging in a counterbalanced order. Each session includes negative affect tasks before and after stimulation.
1 session every 48 hours or more
Duration - Two sessions over at least 2 days
Participants complete two sessions with sham stimulation only, with or without placebo intervention. Doctors deliver placebo messaging and monitor patients' responses during these sessions.
1 session every 48 hours or more
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
6
Have more questions? Get in touch with our team for quick support
Dasha A Sandra, Jay A Olson, Ellen J Langer...
https://pubmed.ncbi.nlm.nih.gov/37405829/Emma Acerbo, Aude Jegou, Charlotte Luff...
https://pubmed.ncbi.nlm.nih.gov/36061593/Pierre Vassiliadis, Elena Beanato, Traian Popa...
https://pubmed.ncbi.nlm.nih.gov/38811696/Ines R Violante, Ketevan Alania, Antonino M Cassarà...
https://pubmed.ncbi.nlm.nih.gov/37857775/Nir Grossman, David Bono, Nina Dedic...
https://pubmed.ncbi.nlm.nih.gov/28575667/Maximilian J Wessel, Elena Beanato, Traian Popa...
https://pubmed.ncbi.nlm.nih.gov/37857774/Jill von Conta, Florian H Kasten, Klaus Schellhorn...
https://pubmed.ncbi.nlm.nih.gov/35839572/Trustees of Dartmouth College
Lead Sponsor